Volume 14 Supplement 3

Abstracts from the 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014)

Open Access

Host factors influencing the activation of tuberculosis in HIV positive individuals with latent TB infection

  • Kamakshi Prudhula Devalraju1,
  • Sharada Ramseri Sunder1,
  • Vijaya Lakshmi Valluri1Email author and
  • Arunabala Chowdary1
BMC Infectious Diseases201414(Suppl 3):E16

DOI: 10.1186/1471-2334-14-S3-E16

Published: 27 May 2014

Background

TB kills 1.3 million persons annually, including 275,000 people in India. An estimated 40% of the population in India has LTBI (Latent Tuberculosis Infection), a significant percentage of them being infected with HIV. HIV infection increases the likelihood of LTBI progressing to active TB. Vaccination and immunotherapeutic strategies are alternative approaches that contribute greatly to TB control in HIV+ persons with LTBI.

Methods

Peripheral blood was drawn from, HIV+ and HIV- individuals with and without LTBI. PBMC and CD14+ monocytes were isolated and 2 million cells were cultured with γ irradiated M. tuberculosis H37Rv, CFP-10. Cultures were terminated after 96 hours, and cells were stained for CD4, CD25, FOXP3 and D4GDI. IFN-γ, IL-17, IL-22 were estimated in the supernatants by ELISA. RNA was isolated from CD14 cells and Realtime PCR was performed to quantitate c-maf expression. P<0.05 was considered statistically significant.

Results

In response to M. tuberculosis, FoxP3+ cells expand in HIV+ and healthy LTBI+ donors. In contrast, D4GDI+FoxP3+ cells expand only in healthy LTBI+ individuals. IL-17 and IL-22 are significantly high in HIV-LTBI+ individuals, increased c-maf expression in monocytes was observed in HIV+ LTBI+ individuals

Conclusions

IL-17 and IL-22 can be helpful to control reactivation of tuberculosis in HIV+ individuals.

Authors’ Affiliations

(1)
LEPRA India – Blue Peter Public Health & Research Centre

Copyright

© Devalraju et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement